
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
A drug called methoclopramide is used to treat esophageal and stomach issues. It is frequently used to treat and prevent nausea and vomiting, to assist those who have gastroesophageal reflux disease in having their stomachs empty more quickly, and to treat and prevent nausea and vomiting in healthy individuals.
Moreover, migraine headaches are treated with it. The anti-sickness drug metoclopramide is used to treat nausea and vomiting.
It might not be appropriate for some people, such as those who have Parkinson's disease, epilepsy, high blood pressure, cirrhosis, kidney disease, congestive heart failure, or preexisting gastrointestinal issues (such as haemorrhage, obstruction, or perforation); pheochromocytoma; or a history of intolerance to metoclopramide.
The Global Metoclopramide Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Metoclopramide Injection Is Introduced by Teva The generic version of Reglan injection made by Baxter, called Metoclopramide Injection, has been introduced by Teva.
Metoclopramide is an antidopaminergic indicated for relief of symptoms associated with acute and recurrent diabetic gastric stasis, prophylaxis of vomiting associated with emetogenic cancer chemotherapy, prophylaxis of postoperative nausea and vomiting in those circumstances where nasogastric suction is undesirable, to facilitate small bowel intubation in adults and paediatric patients in whom the tube does not pass the pylorus with conventional manoeuvres, and to stimulate gastric emptying and intestinal transit of barium in cases where delayed emptying interferes with radiological examination of the stomach and/or small intestine.
Metoclopramide works by stimulating motility of the upper gastrointestinal tract without stimulating gastric, biliary, or pancreatic secretions. Along with accelerating gastric emptying and intestinal transit, it also makes the pyloric sphincter and duodenal bulb more relaxed.
It also increases the tone and amplitude of gastric contractions and the peristalsis of the duodenum and jejunum. Additionally, it raises the lower esophageal sphincter's resting tone.
Metoclopramide Injection is available in a 5mg/mL strength in 2mL single-use vials Through many acquisitions that integrated and boosted its expertise in novel and generic medications, as well as new therapeutic areas and markets, Teva saw considerable global growth. Teva is one of the top 15 pharmaceutical firms in the world today and a pioneer in the development of speciality and generic drugs.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |